Two to tango: engineered T cells against AML

Blood. 2024 Feb 8;143(6):476-478. doi: 10.1182/blood.2023023004.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Humans
  • Leukemia, Myeloid, Acute* / therapy
  • Receptors, Antigen, T-Cell
  • T-Lymphocytes*

Substances

  • Receptors, Antigen, T-Cell